|
Volumn 36, Issue 9, 2005, Pages
|
Use of multimodal MRI and novel endovascular therapies in a patient ineligible for intravenous tissue plasminogen activator.
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
FIBRINOLYTIC AGENT;
TISSUE PLASMINOGEN ACTIVATOR;
AGED;
ARTICLE;
BLEEDING;
BLOOD PRESSURE;
BLOOD VESSEL TRANSPLANTATION;
BRAIN INFARCTION;
BRAIN ISCHEMIA;
CASE REPORT;
CATHETERIZATION;
CEREBROVASCULAR ACCIDENT;
DIFFUSION WEIGHTED IMAGING;
FIBRINOLYTIC THERAPY;
HUMAN;
INSTRUMENTATION;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
METHODOLOGY;
MIDDLE CEREBRAL ARTERY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PATHOLOGY;
RISK;
THROMBECTOMY;
TIME;
AGED;
BLOOD PRESSURE;
BLOOD VESSEL PROSTHESIS IMPLANTATION;
BRAIN ISCHEMIA;
CATHETERIZATION;
CEREBRAL INFARCTION;
CEREBROVASCULAR ACCIDENT;
DIFFUSION MAGNETIC RESONANCE IMAGING;
FIBRINOLYTIC AGENTS;
HEMORRHAGE;
HUMANS;
INFUSIONS, INTRAVENOUS;
MAGNETIC RESONANCE IMAGING;
MALE;
MIDDLE CEREBRAL ARTERY;
RISK;
THROMBECTOMY;
THROMBOLYTIC THERAPY;
TIME FACTORS;
TISSUE PLASMINOGEN ACTIVATOR;
MLCS;
MLOWN;
|
EID: 33644797466
PISSN: None
EISSN: 15244628
Source Type: Journal
DOI: 10.1161/01.str.0000177515.14055.d0 Document Type: Article |
Times cited : (12)
|
References (0)
|